Amyloid-β positivity is less prevalent in cognitively unimpaired <i>KLOTHO</i> KL-VS heterozygotes

KL-VS<sub>HET</sub> is associated with lower odds of being positive for Aβ, regardless of whether one is also positive for tau. Conversely, the likelihood of being tau positive did not differ based on KL-VS genotype. Our findings add to the growing <i>KLOTHO</i> literature and suggests the need for further research focused on understanding the mechanisms underlying KL-VS-related putative resilience to AD.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2024-11-01
DOI
https://doi.org/10.1177/13872877241289785
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes

Tobey J. Betthauser, Dena B. Dubal, Julian M. Gaitán, Noah Cook et al.
Journal of Alzheimer s Disease
Parathyroid Disorders and Treatments
article

Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes

Tobey J. Betthauser, Dena B. Dubal, Julian M. Gaitán, Noah Cook, Gwendlyn Kollmorgen, Henrik Zetterberg, Ira Driscoll, Sterling C. Johnson, Cynthia M. Carlsson, Matthew Glittenberg, Clara Quijano‐Rubio, Ozioma C. Okonkwo, Sanjay Asthana, Kaj Blennow
article en

Abstract

KL-VS<sub>HET</sub> is associated with lower odds of being positive for Aβ, regardless of whether one is also positive for tau. Conversely, the likelihood of being tau positive did not differ based on KL-VS genotype. Our findings add to the growing <i>KLOTHO</i> literature and suggests the need for further research focused on understanding the mechanisms underlying KL-VS-related putative resilience to AD.

Journal of Alzheimer s DiseaseVol. 102(2)
Roche (Switzerland) (CH), University of Wisconsin–Madison (US), University of California, San Francisco (US), Sahlgrenska University Hospital (SE), Roche Pharma AG (Germany) (DE), Geriatric Research Education and Clinical Center (US), UK Dementia Research Institute (GB), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), University of Gothenburg (SE)
Eli Lilly and Company, Biogen, Prothena, Apellis Pharmaceuticals, Eisai, Knut och Alice Wallenbergs Stiftelse, Novo Nordisk, Vetenskapsrådet, Sahlgrenska Universitetssjukhuset, Siemens Healthineers, Julius Clinical, Avid Radiopharmaceuticals, Geriatric Research Education and Clinical Center, National Institute on Aging, National Institute of Neurological Disorders and Stroke, NIH Clinical Center
Openalex Percentile: Top 70%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.